2009 Clinical Research Training Institute Summer Workshop
2009 Clinical Research Training Institute Summer Workshop
批准号:
7744297
负责人:
Michael R. DeBaun
金额:
$4.25万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2010-07-31
关键词:
Academic Medical CentersAmerican Society of HematologyApplications GrantsAttentionBenignCanadaChargeClimactericClinicalClinical ProtocolsClinical ResearchClinical Research ProtocolsData AnalysesDisabled PersonsDisciplineDistrict of ColumbiaDoctor of PhilosophyEducationEducational CurriculumEducational workshopEnsureEpidemiologyFacultyFosteringFundingGoalsGrantHealth Services ResearchHematological DiseaseHematologistHematologyInstitutesK-Series Research Career ProgramsLearningLifeMalignant - descriptorMentorsMethodsMindMinorityOhioParticipantPatient CarePatientsPlantsPositioning AttributeProtocols documentationRecommendationResearchResearch DesignResearch MethodologyResearch PersonnelResearch ProposalsResearch TrainingResourcesRoleScheduleSeedsSocietiesStudentsTimeTrainingTraining ProgramsTraining and EducationUnited States National Institutes of HealthUniversitiesUpper armWashingtonWomanabstractingcareerdesigndirect applicationexperiencefollow-upforgingimprovedinterestmeetingsmembermennoveloncologyprogramssuccesstool
中文摘要
描述(由申请人提供):
美国血液学会(ASH)临床研究培训研究所是一个为期一年的强化项目,提供有关临床研究方法的广泛教育。该研究所面向在美国和加拿大学术医疗中心完成培训三年内的血液学和血液肿瘤学研究员和初级教员。临床研究培训研究所的目标是培养一批从事临床血液学研究的研究人员,并为他们配备工具和获得资源,使他们的想法成为现实。
该计划包括一个为期一周的夏季研讨会,一个与ASH年会同时举行的12月会议,以及春季在ASH总部举行的后续会议。然而,为了这次拨款申请的目的,我们将重点关注定于2009年8月1日至7日举行的夏季研讨会。本周将包括上午的全体会议、下午的分组会议和一对一的指导机会。
夏季工作坊的六个部分是:1)临床研究方法学原则,2)血液学临床研究的当前问题,3)血液学临床研究成功的战略,4)小组辅导会议(3-4名学生,2-3名教员),以制定和完善学员的研究建议,5)血液学临床研究领导者的职业回顾,以及6)学员对他们的研究建议的陈述。
该课程将每个组成部分贯穿整个星期,将理论概念与参与者协议的应用相结合。第一天,学员将提出他们的研究计划。在最后一天,他们再次提出他们的建议,强调在小组辅导会议期间所做的改进。
该项目最受重视的方面之一是教职员工的亲密作用。通过与受训者接近1:1的比率,培养了对临床血液学研究的兴趣,为每个参与者量身定做信息,并与领导人建立联系,从而为参与者提供在临床血液学领域取得成功所需的工具。(摘要结束)
英文摘要
DESCRIPTION (provided by applicant):
The American Society of Hematology (ASH) Clinical Research Training Institute is an intensive, year long program to provide a broad education about clinical research methods. The Institute is geared toward hematology and hematology-oncology fellows and junior faculty within three years of completion of their training at academic medical centers in the U.S. and Canada. The goal of the Clinical Research Training Institute is to produce a group of researchers for careers in clinical hematology research and equip them with the tools and access to resources to make their ideas a reality.
The program consists of a summer week-long workshop, a December meeting in conjunction with the ASH Annual Meeting and a follow-up meeting in the spring at ASH headquarters. For purposes of this grant application however, we will focus on the summer workshop scheduled for August 1-7, 2009. This week will consist of morning plenary sessions, afternoon breakout sessions, and one-on-one mentoring opportunities.
The six components of the summer workshop are: 1) principles of clinical research methodology, 2) current issues in hematology clinical research, 3) strategies for successful clinical research careers in hematology, 4) small group mentoring sessions (3-4 students with 2- 3 faculty) to develop and refine trainees' research proposals, 5) career retrospectives from leaders in hematology clinical research, and 6) trainees' presentations of their research proposals.
The curriculum spreads each component throughout the week, to integrate theoretical concepts with application to the participants' protocols. On the first day, the trainees will present their research proposal. On the final day, they again present their proposal, emphasizing the improvements made during the small group mentoring sessions.
One of the most valued aspects of the program is the intimate role of the faculty. Through a near one-to-one ratio with the trainees, interest in clinical hematology research is fostered, information is tailored to each participant and contacts with leaders are forged thereby giving participants the tools they need for a successful career in clinical hematology. (End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
-
批准号:10596076
-
项目类别:
-
资助金额:$84.97万
-
财政年份:2021
-
负责人:Michael R. DeBaun
-
依托单位:
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
-
批准号:10154363
-
项目类别:
-
资助金额:$69.11万
-
财政年份:2021
-
负责人:Michael R. DeBaun
-
依托单位:
Clinical and genetic risk factors associated with adverse long-term health outcomes after curative therapies in individuals with sickle cell disease
-
批准号:10371225
-
项目类别:
-
资助金额:$85.49万
-
财政年份:2021
-
负责人:Michael R. DeBaun
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10613453
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:Michael R. DeBaun
-
依托单位:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
-
批准号:8468275
-
项目类别:
-
资助金额:$189.75万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
-
批准号:8727301
-
项目类别:
-
资助金额:$25.7万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
-
批准号:9069964
-
项目类别:
-
资助金额:$190.98万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
-
批准号:9405682
-
项目类别:
-
资助金额:$63.26万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
-
批准号:8722610
-
项目类别:
-
资助金额:$172.94万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease
-
批准号:8999245
-
项目类别:
-
资助金额:$5.03万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia
-
批准号:8568575
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2013
-
负责人:Michael R. DeBaun
-
依托单位:
ASTHMA AND NOCTURNAL HYPOXEMIA IN SICKLE CELL ANEMIA
-
批准号:7603402
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2007
-
负责人:Michael R. DeBaun
-
依托单位:
IMPORTANCE OF HEMODYNAMIC FACTORS IN THE PROGNOSIS OF STROKE IN SICKLE CELL
-
批准号:7377215
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2006
-
负责人:Michael R. DeBaun
-
依托单位:
IMPORTANCE OF HEMODYNAMIC FACTORS IN THE PROGNOSIS OF STROKE IN PATIENT WITH SCD
-
批准号:7377269
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2006
-
负责人:Michael R. DeBaun
-
依托单位:
SCREENING AND TREATMENT OF SILENT INFARCTS FOR CHILDREN WITH SICKLE CELL DISE
-
批准号:7377276
-
项目类别:
-
资助金额:$0.17万
-
财政年份:2006
-
负责人:Michael R. DeBaun
-
依托单位:
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia II
-
批准号:8137139
-
项目类别:
-
资助金额:$67.79万
-
财政年份:2005
-
负责人:Michael R. DeBaun
-
依托单位:
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia
-
批准号:7115874
-
项目类别:
-
资助金额:$204.76万
-
财政年份:2005
-
负责人:Michael R. DeBaun
-
依托单位:
SCREENING AND TREATMENT OF SILENT INFARCTS FOR CHILDREN WITH SICKLE CELL DISE
-
批准号:7198781
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2005
-
负责人:Michael R. DeBaun
-
依托单位:
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia II
-
批准号:7987638
-
项目类别:
-
资助金额:$74.77万
-
财政年份:2005
-
负责人:Michael R. DeBaun
-
依托单位:
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia
-
批准号:6898634
-
项目类别:
-
资助金额:$187.1万
-
财政年份:2005
-
负责人:Michael R. DeBaun
-
依托单位: